Dallas, TX, January 08, 2017 --(PR.com
)-- APAC point-of-care testing market is expected to reach USD 11.5 billion by 2024 from USD 3.9 billion in 2016, growing at a CAGR of 14.6% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
The market is segmented on the basis of product, prescription mode, distribution channel, end user and geography.
On the basis of product the market is segmented into 13 major segments which includes blood glucose testing kits, cardiometabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy and fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits, and others.
Request for sample pages: http://databridgemarketresearch.com/reports/apac-point-care-testing-poct-market-trends-forecast-2024/
Based on prescription mode, the APAC point-of-care testing market is segmented into prescription based testing and over-the-counter (OTC) testing. The OTC testing is projected to witness higher growth during the forecast period.
On the basis of distribution channel, the market is segmented into direct tenders and retail.
On the basis of end users, the market is segmented into hospital, clinics, ambulatory care, home healthcare, and research laboratory.
Based on geography the market is segmented into 11 countries, China, Japan, India, South Korea, Australia, Thailand, Malaysia, Singapore, Indonesia, Philippines and Rest of APAC. The report includes company share data for different countries including China, Japan, India, South Korea, Australia and Singapore.
Read more: http://databridgemarketresearch.com/reports/apac-point-care-testing-poct-market-trends-forecast-2024/
The key players operating in this market are Abbott Laboratories, Inc., Roche Diagnostics Limited, Siemens AG, Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., Instrumentation Laboratory, PTS Diagnostics, Abaxis, Inc., Medtronic, Accriva Diagnostics, Opti Medical, Sienco, Inc., Alpha Scientific, AccuBioTech Co., Ltd., ACON Laboratories, Inc., Acrongenomics, AccuBioTech Co., Ltd., bioMérieux, Biomerica, Inc., Atlas Genetics Ltd., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Medica Corporation, and Nova Biomedical among others.
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.